blindness

In a first, doctors injected the gene-editing tool CRISPR directly into cells in patients' eyes. The experiment helped these vision-impaired patients see shapes and colors again.

The unprecedented study involves using the gene-editing technique CRISPR to edit a gene while it's still inside a patient's body. In exclusive interviews, NPR talks with two of the first participants.

Dotty St. Amand, CEO of Lighthouse of Southwest Florida, which assists people with visual impairment, says that getting clients vaccinated is of great concern.

Florida State University has posted signs on campus and inside buildings asking students to wear masks and practice social distancing. But some students are having a difficult time accessing all of Florida State University's COVID-19 guidelines.

A deal finalized over the weekend will allow blind voters to fill out ballots secretly at home, putting an end to a broader legal tangle over Florida’s…

Software that can replace doctors for certain tasks has a big responsibility. The Food and Drug Administration is now figuring out how to determine when computer algorithms are safe and effective.

A first-of-its kind genetic treatment for blindness will cost $850,000 per patient, making it one of the most expensive medicines in the world and raising…

Supplements with the antioxidant lutein and omega-3 fatty acids didn't stop age-related macular degeneration, the leading cause of blindness in the United States, a new study suggests. But other antioxidants, including vitamins C and E, do seem to help.